- Biogen to bring its global drug portfolio to India
US-based Biogen Idec plans to roll out its entire range of medicines in the fast-growing, Rs 40,000-crore Indian retail drug market over th...
19 Feb, 2010, 12.14 AM IST
- US-based Merck to double workforce by year-end
US-based $25-billion Merck also plans to launch drugs targeted to Indian patients and introduce a competitive pricing pattern.
22 Apr, 2008, 12.06 AM IST
- Biogen for inlicensing deal with Indian cos
US-based biotech company Biogen Idec, is looking for partnerships across the pharma value chain, including in-licensing of new experimental...
01 Sep, 2007, 02.22 AM IST
- Big Pharma seeks biotech dose to spur growth
Vincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.
13 Jan, 2007, 02.59 AM IST